Waterlily, a startup that aims to predict long-term care needs using artificial intelligence, secured $7 million in seed funding.
You are here
Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders
Fri, 01/10/2020 - 10:11 - Laurie Orlov
To improve treatment for patients with illnesses ranging from Alzheimer’s to insomnia and substance use disorder.
category tags:
Tuesday, January 7, 2020